HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chunxia Zhou Selected Research

alanyl-tyrosyl-alanine

7/2022Pentapeptide AYP from Isochrysis Zhanjiangensis Exhibits Antiangiogenic Activity in HT1080 Cells and HUVECs by Suppressing Migration and Invasion In Vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chunxia Zhou Research Topics

Disease

22Neoplasms (Cancer)
07/2022 - 06/2005
7Inflammation (Inflammations)
08/2022 - 04/2020
4Neoplasm Metastasis (Metastasis)
03/2015 - 10/2006
3Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 01/2015
3Carcinoma (Carcinomatosis)
03/2018 - 12/2012
2Hypoxia (Hypoxemia)
11/2021 - 12/2015
2Hypertension (High Blood Pressure)
01/2020 - 07/2019
2Prostatic Neoplasms (Prostate Cancer)
01/2007 - 06/2005
1Atherosclerosis
06/2022
1B-Cell Lymphoma (Lymphoma, B Cell)
03/2021
1Vascular System Injuries
04/2020
1Stomach Neoplasms (Stomach Cancer)
01/2020
1Adenoid Cystic Carcinoma (Cylindroma)
03/2018
1Ulcer
01/2017
1Reperfusion Injury
01/2017
1Myocardial Infarction
01/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2015
1Ovarian Epithelial Carcinoma
01/2015
1Lung Neoplasms (Lung Cancer)
02/2014
1Residual Neoplasm
12/2012
1Melanoma (Melanoma, Malignant)
10/2006

Drug/Important Bio-Agent (IBA)

8VaccinesIBA
01/2018 - 06/2005
6AntigensIBA
02/2014 - 06/2005
3Pharmaceutical PreparationsIBA
07/2022 - 12/2012
3Peptides (Polypeptides)IBA
06/2022 - 01/2020
3Monoclonal AntibodiesIBA
01/2016 - 10/2006
3DNA (Deoxyribonucleic Acid)IBA
10/2006 - 04/2006
3DNA VaccinesIBA
04/2006 - 06/2005
2Caspase 9IBA
06/2022 - 03/2021
2Matrix Metalloproteinases (MMPs)IBA
01/2022 - 11/2021
2Mitogen-Activated Protein KinasesIBA
11/2021 - 04/2020
2Proteins (Proteins, Gene)FDA Link
03/2021 - 02/2014
2Angiotensin IIIBA
04/2020 - 07/2019
2Therapeutic UsesIBA
05/2019 - 09/2008
2Fluorouracil (Carac)FDA LinkGeneric
01/2016 - 12/2012
2Cisplatin (Platino)FDA LinkGeneric
12/2015 - 01/2015
1Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
08/2022
1alanyl-tyrosyl-alanineIBA
07/2022
1prolylglutamic acidIBA
07/2022
1oxidized low density lipoproteinIBA
06/2022
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2021
1Angiogenesis InhibitorsIBA
11/2021
1Cytochrome P-450 CYP2E1 (CYP2E1)IBA
03/2021
1Caspase 3 (Caspase-3)IBA
03/2021
1Glutathione (Reduced Glutathione)IBA
03/2021
1Superoxide DismutaseIBA
03/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1LipopolysaccharidesIBA
01/2021
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
04/2020
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
04/2020
1vascular factorIBA
04/2020
1Captopril (Capoten)FDA LinkGeneric
01/2020
1Polystyrenes (Polystyrene)IBA
01/2020
1Tetracycline (Achromycin)FDA LinkGeneric
01/2020
1AntibodiesIBA
05/2019
1N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA
03/2018
1geranylgeranylacetone (teprenone)IBA
01/2017
1Aquaporin 6IBA
04/2016
1aquaporin 8IBA
04/2016
1SuspensionsIBA
01/2016
1Long Noncoding RNAIBA
12/2015
1LuciferasesIBA
12/2015
1NucleotidesIBA
12/2015
1RNA (Ribonucleic Acid)IBA
12/2015
1Biomarkers (Surrogate Marker)IBA
12/2015
1Aquaporins (Water Channels)IBA
12/2015
1Aquaporin 5IBA
12/2015
1Granzymes (Granzyme)IBA
03/2015
1EnzymesIBA
02/2014
1CytokinesIBA
02/2014
1Neoplasm Antigens (Tumor Antigens)IBA
02/2014
1ImmunosorbentsIBA
02/2014
1Interleukin-2 (IL2)IBA
02/2014
1Complement System Proteins (Complement)IBA
12/2012
1Epidermal Growth Factor (EGF)IBA
12/2010
1Rituximab (Mabthera)FDA Link
09/2008
1Telomerase (Telomerase Reverse Transcriptase)IBA
10/2006
1HLA Antigens (Human Leukocyte Antigens)IBA
10/2006
1Immunoglobulin G (IgG)IBA
04/2006
1Immunoglobulin Fc FragmentsIBA
04/2006
1EpitopesIBA
06/2005

Therapy/Procedure

8Immunotherapy
05/2019 - 10/2006
6Therapeutics
01/2017 - 06/2005
3Drug Therapy (Chemotherapy)
03/2018 - 12/2012
1Intravenous Injections
05/2019
1Aftercare (After-Treatment)
11/2007